In the recent days of the red net news news (wing wing, a correspondent) on 27 may, the blood medicine unit attached to the first hospital of the university of south china successfully completed a single blood-free blood exchange, and the patient, li, held the hands of the health-care staff with emotion and gratitude for their excellent medical skills. After three years of multiple osteoporosis, he experienced symptoms of physical inactivity, joint pain, and post-activity dysentery and aerobics, the symptoms improved markedly and the quality of life improved significantly。
After their first admission to hospital, after careful assessment by the hospital's blood-surgery team, the treatments offered to them included active rehydration therapy, integrated treatments such as immunotherapy, and a new technology, plasma-free replacement. These treatments not only effectively remove harmful substances from the patient's body, but also alleviate the symptoms of disease-induced discomfort. Throughout the treatment, there was no adverse reaction。
The patient was admitted to the hospital because of the choice of chemotherapy, and although the osteomenoma was in a defusing phase, there were still high levels of osteoglobins, anaemia and a strong demand for a new plasma replacement before cyclical chemotherapy began. Following the completion of the replacement, the mental state of the patient has improved significantly, while medical indicators are gradually returning to normal, laying a solid foundation for the next phase of treatment。
Multiple osteomenoma is a malignant plasma cell tumour, often accompanied by a single cloned immunoglobin or light chain (mprotein) overproduction. Incomplete kidney functioning seriously affects the quality of life and the prognosis of patients with multiple osteoporosis, with about 2 to 12 per cent of patients requiring lifelong dialysis due to kidney failure. The lack of plasma, which is one of the most important means of treatment, severely constrains the clinical application of the technology。
Since last year, in order to increase the number of patients treated in a timely manner, a single blood internal blood blood cell separation team attached to a hospital in south china has, through learning, re-discussion and practice, finalized the best alternative combination of liquids and the best replacement amount, replacing the traditional plasma replacement method, which relies on plasma. Clinical data indicate that the application of plasma replacements in patients with multiple osteomenoma combined with high sticky sepsis and an incomplete kidney, with single replacements of 25-30 per cent, has effectively improved the patient's clinical symptoms, extended the patient's lifespan and made replacements faster and easier and safer, saving nearly $2,000 compared to traditional plasma replacements, significantly reducing the financial burden on the patient。
South china's single-segregation team, with 15 years of experience and skill, is one of the few teams in hunan province with comprehensive knowledge of white cells, red cells, plate removal, plasma replacement, and blood stem cell collection techniques. In the future, the team will be active in expanding the application of new technologies to provide efficient treatment for patients with severe myocardia, greenbali, and systemic erythalamus。
